Dr. Ron Gladue Medical Advisor

Accomplished pharmaceutical scientific and strategic leader with over 34 years of experience in drug discovery and development for immunological diseases (immune-oncology, autoimmunity, antibody-based therapies for infectious disease). Lead over 14 drug discovery programs and co-inventor on 13 patents. Involved with numerous strategic initiatives receiving awards for innovation, team work, and specific accomplishments. Expertise in innate and adaptive immunity and the development of small molecules and biologics as therapeutic agents from idea to clinic. Published over 43 manuscripts, 3 book chapters, and 3 reviews and gave over 54 presentations at national and international meetings. Key Areas of Research Immune based mechanisms of disease, immune modulation, antibody based therapies, T cell immunology, adaptive and innate immune mechanisms, chemokines, Toll-like receptors, cancer immunotherapy

Dr. Agnes Matczuk Medical Advisor

Dr. Agnes Matczuk is in clinical practice at Fairfield County Allergy, Asthma, and Immunology in various locations in Connecticut. Dr. Agnes (Agnieszka) Matczuk graduated from Karol Marcinkowski University School of Medicine, Poznan, Poland.  Dr. Matczuk completed her internship and residency in Pediatrics at Beth Israel Medical Center in New York City and a Fellowship in Allergy and Immunology at Yale University School of Medicine. She remains on staff at Yale University School of Medicine as an Assistant Clinical Professor in Pediatrics.Dr. Matczuk was voted by peers to Connecticut Top Docs. Currently, Dr. Matczuk holds the following positions in addition to her FCAAIA practice: Attending Physician at Greenwich Hospital Attending Physician and Assistant Clinical Professor at Yale University/Yale New Haven Hospital Certifications: Diplomat, American Board of Allergy & Immunology Diplomat, American Board of Pediatrics

Dr. Louis M. Mendelson Medical Advisor

15Dr. Mendelson is a board certified allergist and clinical immunologist. Dr. Mendelson is a clinical professor of pediatrics at the University of Connecticut School of Medicine and has hospital appointments at Connecticut Children's Medical Center and Hartford Hospital. Dr. Mendelson is in charge of the Division of Allergy and Immunology at the Connecticut Children's Medical Center, is co-director of the Food Allergy Clinic at Connecticut Children's Medical Center, and serves as medical advisor to the local Food Allergy/Education Support Group. Dr. Mendelson received his medical degree from the Medical College of Virginia. Dr. Mendelson completed his pediatric residency at Bronx Municipal Hospital Center at the Albert Einstein School of Medicine in New York and his allergy and immunology fellowship at the University of California in San Diego. Dr. Mendelson's research and writing interest include penicillin allergy, food allergy, anaphylactic reactions, asthma, and vernal conjunctivitis. He is board certified in pediatrics and allergy and immunology. Dr. Mendelson is the past president of the New England Society of Allergy and the Connecticut Society of Allergy and Immunology. He is a fellow of the American Academy of Allergy, Asthma, and Immunology, and served on the Board of Directors. Dr. Mendelson holds memberships in the American College of Allergy, Asthma, and Immunology, the New England Society of Allergy, and the Connecticut Allergy and Immunologic Society. In 2004 Dr. Mendelson was one of the founders of AllerQuest, a company originated to bring PrePen back to market. AllerQuest obtained FDA approval for PrePen in the fall of 2009. Dr. Mendelson is the company's president and CEO. He is the originator of the Food Allergy/Education Support Group for the greater Hartford area. Dr. Mendelson is the 2000 recipient of the "Distinguished Clinician Award" presented by the American Academy of Allergy, Asthma and Immunology. Dr. Mendelson was honored with the Food Allergy Network's "Marial C. Furlong Award for Making a Difference" in 1999. Dr. Mendelson was voted "The Best Allergist in 1999" by a Channel 3 viewer poll. He has been recognized by the Connecticut Magazine list of "Best Doctors in Connecticut,"Hartford Magazine "Greater Hartford's Top Docs," and The Best Doctors in America. In 2010, Dr. Mendelson was honored to receive the American Academy of Allergy, Asthma and Immunology RSLAAIS Leadership Award.

Dr. Anthony Porto Medical Advisor

Anthony is a board certified pediatrician and board certified pediatric gastroenterologist. He is an Associate Professor of Pediatrics and Associate Clinical Chief of Pediatric Gastroenterology at Yale University and Director, Pediatric Gastroenterology at Greenwich Hospital in Greenwich, CT. He is also the medical director of the Yale Pediatric Celiac Program. He sees patients in Greenwich, Trumbull, and New Haven, CT. He has won numerous awards including the Norman J. Seigel Award at Yale University in 2015 for leadership and providing outstanding clinical care as well as Physician of the Year during his time at Morgan Stanley Children’s Hospital. He has been named Castle Connolly Top Doctors since 2012. He is on the American Academy of Pediatrics PREP Gastroenterology Advisory Board and writes web-based education materials as a member of the Public Education committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition. Anthony is interested in nutrition, especially in the care of children with difficulty gaining weight, feeding issues, and celiac disease. He graduated from Columbia University with a Bachelor of Arts in Neuroscience and Behavior and attended medical school at Tufts University School of Medicine where he also received his master of public health. He completed his pediatric residency at the Children’s Hospital at Montefiore Medical Center and his pediatric gastroenterology fellowship at the Morgan Stanley Children’s Hospital of New York at Columbia University.

Dr. Henry Showell Advisor

Henry Showell worked at Pfizer Central Research in Groton, CT for 20 years (1981 - 2001) where his laboratory was involved in Arthritis and Allergy/Immunology drug discovery research programs. During that period Henry's lab contributed to the discovery of multiple novel compounds that entered clinical development. Henry was also a member of multidisciplinary clinical development teams that helped coordinate the advancement of compounds during early phases of clinical development. In his latter years at Pfizer, Henry was a founder member of the DrugPfinder Team at their Cambridge, MA facility. in this role Henry helped establish and manage multiple research collaborations between Pfizer Global Therapeutic Area Teams and academic laboratories in the US, Europe and Asia. Prior to joining Pfizer, Henry held an appointment (1970-1981) In the Department of Pathology at U.Conn Health Center (UCHC) in Farmington, CT. At UCHC Henry worked with Elmer Becker, a renowned Immunologist, where they made several seminal observations on mechanisms of leukocyte chemotaxis in inflammatory diseases that resulted in multiple publications in top tier journals. Henry's first research experience was at Oxford University in the laboratory of Alan Woodin at the Sir William Dunn School of Pathology (1963 -1970) where the research goal was to delineate the mechanisms of leukocyte toxicity of Staphylococcal Leukocidin. Since retiring from Pfizer Henry has served as an ad hoc external adviser to multiple pharmaceutical and biotechnology companies and research foundations. Henry currently serves on the External Advisory Board of the Program in Innovative Therapeutics for Connecticut's Health.